| Customization: | Available |
|---|---|
| Varieties: | Parasite Disease Prevention Medicine |
| Component: | Ponazuril |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name | Ponazuril |
| Appearance | White powder |
| CAS NO. | 69004-04-2 |
| MF | C18H14F3N3O6S |
| MW | 457.38 |
Ponazuril is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by Sarcocystis neurona. More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.
1. Ponazuril is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona.
2. Ponazuril have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.
){kind=link}